THRX Related Analyst Ratings
-
FTN Equity Initiates Coverage on Theravance (THRX) with a Neutral
-
Soleil Securities Initiates Coverage on Theravance (THRX) with a Hold
-
ThinkEquity Initiates Coverage on Theravance (THRX) with a Buy
-
Baird Upgrades Theravance (THRX) to Outperform
-
Credit Suisse Downgrades Theravance (THRX) to Neutral
-
Susquehanna Initiates Coverage on Theravance (THRX) with a Positive
-
Baird Initiates Coverage on Theravance (THRX) with a Neutral
-
Cowen & Co Initiates Coverage on Theravance (THRX) with an Outperform
-
S&P Equity Research Initiates Coverage on Theravance (THRX) with a Buy
-
Credit Suisse Starts Theravance (THRX) at Outperform
-
Piper Jaffray upgrades Theravance (THRX) to Outperform
-
Rodman & Renshaw Starts Theravance (THRX) at Outperform
-
Morgan Stanley downgrades THRX to Equal Weight
-
CSFB downgrades THRX to Underperform
-
Merrill Lynch List Top 2006 Biotech Picks
-
Hearing Merrill Defends THRX from GSK Fallout
-
Merrill Lynch upgrades THRX to Buy
-
Morgan Stanley Stars THRX at Overweight
Back to THRX Stock Lookup
